title: Comparative analysis of hepatic CD14 expression between two different endotoxin shock model mice: relation between hepatic injury and CD14 expression.
abstract: CD14 is a glycoprotein that recognizes gram-negative bacterial lipopolysaccharide (LPS) and exists in both membrane-bound and soluble forms. Infectious and/or inflammatory diseases induce CD14 expression, which may be involved in the pathology of endotoxin shock. We previously found that the expression of CD14 protein differs among the endotoxin shock models used, although the reasons for these differences are unclear. We hypothesized that the differences in CD14 expression might be due to liver injury, because the hepatic tissue produces CD14 protein. We investigated CD14 expression in the plasma and liver in the carrageenan (CAR)-primed and D-galN-primed mouse models of endotoxin shock. Our results showed that severe liver injury was not induced in CAR-primed endotoxin shock model mice. In this CAR-primed model, the higher mRNA and protein expression of CD14 was observed in the liver, especially in the interlobular bile duct in contrast to D-galN-primed-endotoxin shock model mice. Our findings indicated that the molecular mechanism(s) underlying septic shock in CAR-primed and D-galN-primed endotoxin shock models are quite different. Because CD14 expression is correlated with clinical observations, the CAR-primed endotoxin shock model might be useful for studying the functions of CD14 during septic shock in vivo.
authors: Laboratory for Immunopharmacology of Microbial Products, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, Japan.
authors: Hiroyasu
authors: H
authors: Hozumi
authors: Rui
authors: R
authors: Tada
authors: Taisuke
authors: T
authors: Murakami
authors: Yoshiyuki
authors: Y
authors: Adachi
authors: Naohito
authors: N
authors: Ohno
mesh_terms: D000818:Animals; D001652:Bile Ducts / Q000276:immunology / Q000293:injuries / Q000378:metabolism*; D002351:Carrageenan; D004195:Disease Models, Animal; D005260:Female; D005688:Galactosamine; D015870:Gene Expression / Q000276:immunology*; D018950:Lipopolysaccharide Receptors / Q000235:genetics* / Q000276:immunology; D008070:Lipopolysaccharides; D008099:Liver / Q000276:immunology / Q000293:injuries / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D012772:Shock, Septic / Q000097:blood / Q000139:chemically induced / Q000235:genetics* / Q000276:immunology; D012995:Solubility
chemical_list: D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; D005688:Galactosamine; D002351:Carrageenan